Frontlight ResearchEarly access
Trial site
CHU Montpellier - Hôpital Saint Eloi
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer2 trials
- Ulcerative colitis2 trials
- Chronic lymphocytic leukaemia1 trial
- Crohn's disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Epilepsy1 trial
- Follicular lymphoma1 trial
- Liver cirrhosis1 trial
- Mantle cell lymphoma1 trial
- Mitochondrial disease1 trial
- Multiple myeloma1 trial
- Neuroendocrine tumours1 trial
- and 1 more
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed3 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Alfasigma S.p.A.1 trial
- Assistance Publique - Hôpitaux de Paris1 trial
- BeiGene1 trial
- BeOne Medicines1 trial
- Celgene1 trial
- and 6 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Crohn's disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Liver cirrhosis1 recruiting
- Mantle cell lymphoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Terminated
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026